Annexon, Inc. (ANNX)
4.01
+0.60
(+17.60%)
USD |
NASDAQ |
Oct 19, 16:00
4.11
+0.10
(+2.49%)
After-Hours: 04:26
Annexon EPS Diluted (Quarterly) : -0.2754 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2754 |
| March 31, 2026 | -0.2273 |
| December 31, 2025 | -0.2763 |
| September 30, 2025 | -0.3683 |
| June 30, 2025 | -0.3439 |
| March 31, 2025 | -0.367 |
| December 31, 2024 | -0.3287 |
| September 30, 2024 | -0.2489 |
| June 30, 2024 | -0.2275 |
| March 31, 2024 | -0.2052 |
| December 31, 2023 | -0.3566 |
| September 30, 2023 | -0.4311 |
| June 30, 2023 | -0.4677 |
| March 31, 2023 | -0.5237 |
| December 31, 2022 | -0.4751 |
| September 30, 2022 | -0.5106 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.9625 |
| March 31, 2022 | -0.9173 |
| December 31, 2021 | -0.9712 |
| September 30, 2021 | -0.9285 |
| June 30, 2021 | -0.8176 |
| March 31, 2021 | -0.6829 |
| December 31, 2020 | -0.6078 |
| September 30, 2020 | -0.5766 |
| June 30, 2020 | -0.3282 |
| March 31, 2020 | -0.3302 |
| December 31, 2019 | -0.2413 |
| September 30, 2019 | -0.2739 |
| June 30, 2019 | -0.2531 |
| March 31, 2019 | -0.2337 |
| December 31, 2018 | -0.1246 |
| September 30, 2018 | -0.1097 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.35M |
| Total Expenses (Quarterly) | 55.35M |
| Enterprise Value | 515.57M |
| Earnings Yield | -28.61% |
| Normalized Earnings Yield | -28.61 |